LEO Pharma strengthens its commercial organization

The refocused commercial set-up will increase organizational efficiency and alignment across all commercial functions globally

GSK to acquire clinical-stage biopharmaceutical company Affinivax for US$ 3.3 billion

GSK to pay $2.1 billion upfront and up to $1.2 billion in potential development milestones

Evonik to build new lipid production facility for mRNA-based therapies in U.S.

Construction will begin in early 2023, and the plant is scheduled to go onstream in 2025

Mezzion Pharma receives clear FDA path forward for the approval of Udenafil for single ventricle heart disease

US FDA accepts new drug application filed by Avillion for AstraZeneca's PT027

Avillion announces expansion of partnership with AstraZeneca on PT027 and will fund and execute a new Phase 3b study

Jubilant HollisterStier enters into agreement of $149.6 mn with US Govt to expand critical vaccine manufacturing capacity

This agreement is in addition to the $92 million filling line expansion announced in November 2021

Thyrocare unveils new brand identity

New logo reflects Thyrocare’s transformation since 1996 to its current leading position at the cutting edge of Diagnostic services

Novavax initiates phase 3 trial of its COVID-19 omicron booster

Trial will assess safety and antibody responses of NVX-CoV2515 to the Omicron variant of COVID-19

OS-SiA digital pathology scanner developed by OptraSCAN granted US patent

OS-SiA is the industry’s first AI-enabled digital scanner that will provide real-time predictive analysis and actionable insights

Daman collaborates with Janssen to develop digital health tool

The aim is to provide further insights into patients' lives in the effort to deliver better outcomes for people with psoriatic arthritis (PsA)